Paris hospitals’ technology transfer arm generates €17m revenue
18 July 2011
Assistance Publique-Hôpitaux de Paris
generated €17 million in revenues thanks to its technology
transfer arm, OTTLIV, in 2010. OTTLIV (Office of Technology
Transfer, Licensing and Industrial Ventures), which consists of a small team of
professionals, raised income from license fees, royalties and
collaborative research projects.
AP-HP brings together 37 Paris hospitals, including university and
teaching establishments, and enjoys close associations with world-famous
bodies such as Inserm, the CNRS, the Institut Curie, the Institut Gustav
Roussy, the Institut Pasteur, and France’s nuclear energy agency (CEA).
OTTLIV’s mission is to generate the maximum return on AP-HP's
intellectual property and is the single point of entry for industry to
access AP-HP’s IP. It also helps would-be entrepreneurs from AP-HP
create their own companies. Last year, it helped establish five new
startups, adding to the 35 already in business, and bringing the number
of jobs created to 250 in the Paris region.
The 2010 results were revealed last month at OTTLIV’s annual medical
innovation conference, APinnov, where it welcomed a number of American
senior healthcare representatives interested in OTTLIV’s unique
approach. OTTLIV differs from most technology transfer units in focusing
on innovations emanating directly from the hospital environment, as well
as from universities, and on bringing to market products and services
for the greater benefit of the patient, whether developed by researchers
in the lab, by clinicians, by nursing staff at the bedside or by others
involved in the wide-ranging activities conducted under the auspices of
AP-HP.
The 201 requests for technology transfer assistance handled by OTTLIV
in 2010 were a new record for the body, which was created in 1992. They
included 42 patent applications, nine requests for software protection
and 127 projects for partnerships with industry.
“It is really satisfying to see OTTLIV’s efforts to protect and
leverage the innovations produced by AP-HP’s doctors and carers bringing
results and generating revenues,” said Dr Florence Ghrenassia, OTTLIV
director. “We are already intensifying our efforts in industry
collaboration and hope to be able to at least maintain these results in
2011.”